Endocytosis routing sequence peptide for cell delivery systems

Summary of the technology

A range of cell delivery systems are crafted for intracellular delivery such as cationic lipids, protein transduction agents or cell-penetrating peptides. Despite of the large number of techniques, transport of macromolecules are rare and only a small portion of these systems are capable of transporting proteins and only very few of them are delivering antibodies. Possible ways for macromolecular translocation is through endocytosis. In some existing applications there are cell-penetrating peptides with a residue number of about 20 amino acids and these molecules are triggering the clathrin-dependent endocytosis. In the recent patent a short WYKYW pentapeptide is applied to deliver relatively large cargo (antibodies, for example) inside the cell via lipid-raft/caveolin-dependent manner through binding to ganglioside GM1.

University of Szeged

Details of the Technology Offer

The WYKYW peptide based delivery system - in contrast with earlier peptide based delivery systems - targeting the GM1 ganglioside and initiate lipid-raft/caveolin-dependent endocytosis of the peptide and the delivered cargo molecule. Targeting the lipid-raft/caveolin-dependent endocytosis has advantages up against the clathrin-dependent endocytosis. One of these is that the progression of internalized caveolae to endosomes and later lysosomes is very slow or absent, so that allow time for the delivered cargo to escape to the target organelles or cytosol. This way of internalization is also desired as direct escape from internalized compartments of the cargo is much more rapid. Our results showed that WYKYW-tagged IgG complex were successfully delivered into live mammalian cells at extracellular concentrations ranging between 20-160 nM and the escape of the protein was observed. We have found that the internalized compartment is not fused with lysosomes and the cargo molecule left the compartment in an intact state.

Desired business relationship

Patent licensing

Current development status

Laboratory prototypes

Intellectual property status

  • Patent already applied for
  • Patent application number :P1900205
  • Patent already applied for
  • Patent application number :PCTHU2020050023
  • Patent already applied for
  • Patent application number :US 17/616,770
  • Patent already applied for
  • Patent application number :EP3980439

Related Keywords

  • Biological Sciences
  • Medicine, Human Health
  • Medical Technology / Biomedical Engineering
  • Pharmaceutical Products / Drugs
  • Medical Biomaterials
  • Biology / Biotechnology
  • Cellular and Molecular Biology Technology
  • Molecular design Technology
  • Medical Health related
  • Therapeutic
  • Drug delivery and other equipment (including kidney dialysis machines)
  • drug delivery systhem

About University of Szeged

Top of the Hungarian University education; more than 21000 students, with about 4100 students from foreign countries; the highest level of reseach in Hungary; intellectual property portfolio of 41 patent, 8 know-how; numerous parts of the IP prtfolio is licenced or expoited in spin-off enterprises;

University of Szeged

Never miss an update from University of Szeged

Create your free account to connect with University of Szeged and thousands of other innovative organizations and professionals worldwide

University of Szeged

Send a request for information
to University of Szeged

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support